Duo Oncology in UPitt News
University of Pittsburgh Innovation Institute Highlights Duo Oncology’s Progress to First in Human Clinical Trials
We are grateful to the Pitt Innovation Institute for spotlighting Duo Oncology's significant progress toward launching the first human clinical trial of our lead product, DUO-207. DUO-207's journey from groundbreaking chemistry to clinical trials is the culmination of years of NIH-funded research led by Dr. Song Li, further strengthened by investment from VCs and institutional partners. We are excited to bring DUO-207 one step closer to the patients who need it most.
